T1	Participants 146 169	coronary heart diseases
T2	Participants 496 499	CHD
T3	Participants 838 909	patients having angina, ST-T alteration and a defective RBC-K transport
T4	Participants 2083 2138	patients receiving optimal medical treatment for angina
